Your browser doesn't support javascript.
loading
High-Density Lipoprotein Lipidomics in Chronic Kidney Disease.
Lidgard, Benjamin; Hoofnagle, Andrew N; Zelnick, Leila R; de Boer, Ian H; Fretts, Amanda M; Kestenbaum, Bryan R; Lemaitre, Rozenn N; Robinson-Cohen, Cassianne; Bansal, Nisha.
Afiliación
  • Lidgard B; Department of Medicine, University of Washington, Seattle, USA.
  • Hoofnagle AN; Department of Medicine, University of Washington, Seattle, USA.
  • Zelnick LR; Department of Laboratory Medicine & Pathology, University of Washington, Seattle, USA.
  • de Boer IH; Department of Medicine, University of Washington, Seattle, USA.
  • Fretts AM; Department of Medicine, University of Washington, Seattle, USA.
  • Kestenbaum BR; Department of Medicine, University of Washington, Seattle, USA.
  • Lemaitre RN; Department of Epidemiology, University of Washington, Seattle, USA.
  • Robinson-Cohen C; Department of Medicine, University of Washington, Seattle, USA.
  • Bansal N; Department of Medicine, University of Washington, Seattle, USA.
Clin Chem ; 69(3): 273-282, 2023 03 01.
Article en En | MEDLINE | ID: mdl-36644946
ABSTRACT

BACKGROUND:

Patients with chronic kidney disease (CKD) have dysfunctional high-density lipoprotein (HDL) particles as compared with the general population. Understanding the lipid composition of HDL may provide mechanistic insight. We tested associations of estimated glomerular filtration rate (eGFR) and albuminuria with relative HDL abundance of ceramides, sphingomyelins, and phosphatidylcholines in participants with CKD.

METHODS:

We studied 490 participants with CKD from the Seattle Kidney Study. HDL was isolated from plasma; targeted lipidomics was used to quantify the relative abundance of ceramides, sphingomyelins, and phosphatidylcholines per 10 µg of total HDL protein. We evaluated the associations of eGFR and albuminuria with levels of individual lipids and lipid classes (including 7 ceramides, 6 sphingomyelins, and 24 phosphatidylcholines) using multivariable linear regression, controlling for multiple comparisons via the false discovery rate.

RESULTS:

The mean (SD) eGFR was 45 (24) mL/min/1.73 m2; the median (IQR[interquartile range]) albuminuria was 108 (16, 686) mg/g (12.2 [1.8, 77.6] mg/mmol) urine creatinine. After adjusting for demographics, past medical history, laboratory values, and medication use, eGFR was not associated with higher relative abundance of any class of lipids or individual lipids. Greater albuminuria was significantly associated with a higher relative abundance of total ceramides and moderate-long R-chain sphingomyelins, ceramides 220 and 241, hexosylceramide 160, sphingomyelin 160, and phosphatidylcholines 290, 301, and 382; the strongest association was for hexosylceramide 160 (increase per doubling of urine albumin to creatinine ratio 0.022 (95% CI, 0.012-0.032).

CONCLUSIONS:

Greater albuminuria was significantly associated with specific alterations in the lipid composition of HDL in participants with CKD.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Albuminuria / Insuficiencia Renal Crónica Límite: Humans Idioma: En Revista: Clin Chem Asunto de la revista: QUIMICA CLINICA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Albuminuria / Insuficiencia Renal Crónica Límite: Humans Idioma: En Revista: Clin Chem Asunto de la revista: QUIMICA CLINICA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos